The latest price target for Guardion Health Sciences (OTC:GHSI) was reported by Maxim Group on February 2, 2024. The analyst firm set a price target for $0.00 expecting GHSI to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Guardion Health Sciences (OTC:GHSI) was provided by Maxim Group, and Guardion Health Sciences downgraded their hold rating.

There is no last upgrade for Guardion Health Sciences

The last downgrade for Guardion Health Sciences Inc happened on February 2, 2024 when Maxim Group changed their price target from N/A to N/A for Guardion Health Sciences Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Guardion Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Guardion Health Sciences was filed on February 2, 2024 so you should expect the next rating to be made available sometime around February 2, 2025.

While ratings are subjective and will change, the latest Guardion Health Sciences (GHSI) rating was a downgraded with a price target of $0.00 to $0.00. The current price Guardion Health Sciences (GHSI) is trading at is $3.22, which is out of the analyst’s predicted range.